BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17372242)

  • 1. Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer.
    Schildkraut JM; Murphy SK; Palmieri RT; Iversen E; Moorman PG; Huang Z; Halabi S; Calingaert B; Gusberg A; Marks JR; Berchuck A
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):473-80. PubMed ID: 17372242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case-control study of young women.
    Suter NM; Malone KE; Daling JR; Doody DR; Ostrander EA
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):127-35. PubMed ID: 12582022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor exon 1 CAG repeat length and risk of ovarian cancer.
    Spurdle AB; Webb PM; Chen X; Martin NG; Giles GG; Hopper JL; Chenevix-Trench G
    Int J Cancer; 2000 Sep; 87(5):637-43. PubMed ID: 10925355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor variants with short glutamine or glycine repeats may identify unique subpopulations of men with prostate cancer.
    Hakimi JM; Schoenberg MP; Rondinelli RH; Piantadosi S; Barrack ER
    Clin Cancer Res; 1997 Sep; 3(9):1599-608. PubMed ID: 9815849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of tri-nucleotide (CAG and GGC) repeat polymorphism of androgen receptor gene in Taiwanese women with refractory or remission rheumatoid arthritis.
    Yu SF; Cheng TT; Hsu YH; Lai HM; Chen YC; Chiu CK; Lin KM; Chang C; Chen CJ; Kang HY
    Clin Rheumatol; 2007 Dec; 26(12):2051. PubMed ID: 17431729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic CAG and GGC repeat lengths in the androgen receptor gene and prostate cancer risk: analysis of a Brazilian population.
    Silva Neto B; Koff WJ; Biolchi V; Brenner C; Biolo KD; Spritzer PM; Brum IS
    Cancer Invest; 2008 Feb; 26(1):74-80. PubMed ID: 18181049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAG repeat length in exon 1 of the androgen receptor gene is related to age of diagnosis but not germ line BRCA1 mutation status in ovarian cancer.
    Kim SC; Ju W; Mahavni V; Geisler JP; Buller RE
    Int J Gynecol Cancer; 2006; 16 Suppl 1():190-4. PubMed ID: 16515589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The polyglycine and polyglutamine repeats in the androgen receptor gene in Japanese and Caucasian populations.
    Sasaki M; Kaneuchi M; Sakuragi N; Fujimoto S; Carroll PR; Dahiya R
    Biochem Biophys Res Commun; 2003 Dec; 312(4):1244-7. PubMed ID: 14652007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer risk.
    Terry KL; De Vivo I; Titus-Ernstoff L; Shih MC; Cramer DW
    Cancer Res; 2005 Jul; 65(13):5974-81. PubMed ID: 15994977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
    Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
    Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic CAG repeat length within the androgen receptor gene: identification of a subgroup of patients with increased risk of ovarian cancer.
    Santarosa M; Bidoli E; Gallo A; Steffan A; Boiocchi M; Viel A
    Oncol Rep; 2002; 9(3):639-44. PubMed ID: 11956643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophageal cancer risk in relation to GGC and CAG trinucleotide repeat lengths in the androgen receptor gene.
    Dietzsch E; Laubscher R; Parker MI
    Int J Cancer; 2003 Oct; 107(1):38-45. PubMed ID: 12925954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status.
    Bennett CL; Price DK; Kim S; Liu D; Jovanovic BD; Nathan D; Johnson ME; Montgomery JS; Cude K; Brockbank JC; Sartor O; Figg WD
    J Clin Oncol; 2002 Sep; 20(17):3599-604. PubMed ID: 12202660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor (CAG)n polymorphisms and breast cancer risk in a Han Chinese population.
    Dang J; Peng L; Zhong HJ; Huo ZH
    Genet Mol Res; 2015 Aug; 14(3):10258-66. PubMed ID: 26345963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas.
    Li AJ; Scoles DR; Armstrong KU; Karlan BY
    Gynecol Oncol; 2008 May; 109(2):220-5. PubMed ID: 18374401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.
    Hsing AW; Gao YT; Wu G; Wang X; Deng J; Chen YL; Sesterhenn IA; Mostofi FK; Benichou J; Chang C
    Cancer Res; 2000 Sep; 60(18):5111-6. PubMed ID: 11016637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen receptor gene CAG trinucleotide repeats in anovulatory infertility and polycystic ovaries.
    Mifsud A; Ramirez S; Yong EL
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3484-8. PubMed ID: 10999852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of androgen receptor exon 1 CAG repeat length with risk of hepatocellular carcinoma: a case-control study.
    Li K; Zhong C; Wang J; Wang B; He J; Bi J
    Tumour Biol; 2014 Dec; 35(12):12519-23. PubMed ID: 25217983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor gene CAG and GGN polymorphisms in infertile Nigerian men.
    Akinloye O; Gromoll J; Nieschlag E; Simoni M
    J Endocrinol Invest; 2009 Nov; 32(10):797-804. PubMed ID: 20065623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alleles with short CAG and GGN repeats in the androgen receptor gene are associated with benign endometrial cancer.
    Rodríguez G; Bilbao C; Ramírez R; Falcón O; León L; Chirino R; Falcón O; Díaz BP; Rivero JF; Perucho M; Díaz-Chico BN; Díaz-Chico JC
    Int J Cancer; 2006 Mar; 118(6):1420-5. PubMed ID: 16187285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.